125 related articles for article (PubMed ID: 33600871)
1. Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
Wong ET; Huang SH; O'Sullivan B; Persaud V; Su J; Waldron J; Goldstein DP; de Almeida J; Ringash J; Kim J; Hope A; Bratman S; Cho J; Giuliani M; Hosni A; Spreafico A; Hansen A; Tong L; Xu W; Yu E
Radiother Oncol; 2021 Apr; 157():255-262. PubMed ID: 33600871
[TBL] [Abstract][Full Text] [Related]
2. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
3. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
[TBL] [Abstract][Full Text] [Related]
4. Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes.
Sananmuang T; Yu E; Su J; O'Sullivan B; Rathod S; Chan B; Bartlett E; Waldron J; Ringash J; Kim J; Bratman SV; Hope A; Spreafico A; Hansen AR; de Almeida J; Goldstein DP; Witterick I; Tong L; Xu W; Huang SH
Laryngoscope; 2021 Apr; 131(4):E1162-E1171. PubMed ID: 33002201
[TBL] [Abstract][Full Text] [Related]
5. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
[TBL] [Abstract][Full Text] [Related]
6. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
7. MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?
Connor SEJ; Burd C; Sivarasan N; Goh V
Eur Radiol; 2021 Dec; 31(12):9273-9286. PubMed ID: 34009413
[TBL] [Abstract][Full Text] [Related]
8. Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer.
Gaffney J; Ramzan A; Dinizulu T; Maley C; Onamusi O; Motamedi-Ghahfarokhi G; Price G; Metcalf R; Garcez K; Hughes C; Lee L; Thomson D; Price J; Jain Y; McPartlin A
Oral Oncol; 2024 Jan; 148():106645. PubMed ID: 37992488
[TBL] [Abstract][Full Text] [Related]
9. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
10. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer.
Kim DY; Wu HG; Kim JH; Lee JH; Ahn SH; Chung EJ; Eom KY; Jung YH; Jeong WJ; Kwon TK; Kim S; Wee CW
Cancer Res Treat; 2022 Apr; 54(2):406-416. PubMed ID: 34176249
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
[TBL] [Abstract][Full Text] [Related]
13. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
14. Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Rath TJ; Narayanan S; Hughes MA; Ferris RL; Chiosea SI; Branstetter BF
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1405-1410. PubMed ID: 28450437
[TBL] [Abstract][Full Text] [Related]
15. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
[TBL] [Abstract][Full Text] [Related]
17. Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status.
Brewczyński A; Jabłońska B; Mrowiec S; Składowski K; Rutkowski T
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375430
[TBL] [Abstract][Full Text] [Related]
18. Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma.
Lee JY; Garcia-Murillas I; Cutts RJ; De Castro DG; Grove L; Hurley T; Wang F; Nutting C; Newbold K; Harrington K; Turner N; Bhide S
Br J Cancer; 2017 Sep; 117(6):876-883. PubMed ID: 28809864
[TBL] [Abstract][Full Text] [Related]
19. The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer.
Daniels CP; Liu HY; Bernard A; Williams C; Foote MC; Ladwa R; McGrath M; Panizza BJ; Porceddu SV
Radiother Oncol; 2020 Oct; 151():242-248. PubMed ID: 32798595
[TBL] [Abstract][Full Text] [Related]
20. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
